Johnson & Johnson

Johnson & Johnson acquiring V-Wave

V-Wave’s novel and minimally invasive interatrial shunt is designed to treat heart failure and addresses significant treatment gap.

DePuy Synthes receives FDA clearance for TriLEAP

Industry events: Insights on AdvaMed 2022

Top 10 medical device companies by revenue 2020 vs 2021

More from Today's Medical Developments

ZOLLER events will showcase the company’s cutting-edge innovations

THINBIT’s MINI GROOVE ‘N TURN Acme threading inserts

CMMC Roll Out: When Do I Need to Comply? webinar